European Companies Search Engine
EU funding (€3,434,981): Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease Hor23 Sept 2016 EU Research and Innovation programme "Horizon"
Text
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Capital Medical University, Beijing, China.
The visualizations for "China Capital Medical University - EU funding (€3,434,981): Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.